{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:16:40Z","timestamp":1792001800947,"version":"4.4.0"},"reference-count":105,"publisher":"Codon Publications","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.aller.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T23:27:10Z","timestamp":1434410830000},"page":"83-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens\u2013Johnson syndrome, toxic epidermal necrolysis and DRESS)"],"prefix":"10.15586","volume":"44","author":[{"given":"M.T.","family":"Belver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Michavila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bobolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Feito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2015.02.004_bib0530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphamet J Rare Dis"},{"key":"10.1016\/j.aller.2015.02.004_bib0535","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermat Ges"},{"key":"10.1016\/j.aller.2015.02.004_bib0540","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1525-1470.2009.00870.x","article-title":"Retrospective analysis of 32 pediatric patients with anticonvulsivant hypersensitivity syndrome (ACHSS)","volume":"26","author":"Newell","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0545","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.aller.2015.02.004_bib0550","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0555","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pcl.2013.12.001","article-title":"Cutaneous drug reactions in the pediatric population","volume":"61","author":"Noguera-Morel","year":"2014","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.aller.2015.02.004_bib0560","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00130832-200410000-00013","article-title":"The immunological and clinical spectrum of delayed drug induced exanthems","volume":"4","author":"Lerch","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0565","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/pde.12204","article-title":"Case report of drug rash with eosinophilia and systemic symptoms demostrating human herpesvirus-6 reactivation","volume":"30","author":"Ferrero","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0570","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0575","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0580","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.aller.2015.02.004_bib0585","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms; a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Veneorol"},{"key":"10.1016\/j.aller.2015.02.004_bib0590","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0595","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17843286.1999.11754231","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)","volume":"54","author":"Tas","year":"1999","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.aller.2015.02.004_bib0600","first-page":"24","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)","author":"Roujeau","year":"2014","journal-title":"Up ToDate"},{"key":"10.1016\/j.aller.2015.02.004_bib0605","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The Dress syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.aller.2015.02.004_bib0610","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1346-8138.2010.01176.x","article-title":"New aspects of drug-induced hypersensitivity syndrome","volume":"38","author":"Tohyama","year":"2011","journal-title":"J Dermat"},{"key":"10.1016\/j.aller.2015.02.004_bib0615","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","article-title":"A new eruptive fever associates with stomatitis and ophthalmia; report of two cases in children","volume":"24","author":"Steven","year":"1922","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.aller.2015.02.004_bib0620","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis, an eruption resembling scalding of the skin","volume":"68","author":"Lyell","year":"1956","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0625","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/archdischild-2013-303718","article-title":"A review of causes of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children","volume":"98","author":"Ferrandiz-Pulido","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.aller.2015.02.004_bib0630","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens\u2013Johnson s\u00edndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0635","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exudativum multiforme majus Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis in Germany (1990\u20131992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.aller.2015.02.004_bib0640","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0645","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1996.tb03598.x","article-title":"Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"135","author":"Rzany","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0650","first-page":"265","article-title":"Stevens\u2013Johnson s\u00edndrome and toxic epidermal necrolysis in children","volume":"148","author":"Sotelo-Cruz","year":"2012","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.aller.2015.02.004_bib0655","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/BCR.0b013e3181a28c82","article-title":"Toxic epidermal necrolysis in children: medical, surgical, and ophtalmologic considerations","volume":"30","author":"Goyal","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.aller.2015.02.004_bib0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-003-0006-9","article-title":"Immunopharmacology of hypersensitivity reactions to drugs","volume":"3","author":"Naisbitt","year":"2003","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.aller.2015.02.004_bib0665","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/ACI.0b013e3283630cc2","article-title":"Toxic epidermal necrolysis: the year in review","volume":"13","author":"Lee","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0670","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MOP.0b013e32832d1fef","article-title":"An update on Stevens\u2013Johnson s\u00edndrome and toxic epidermal necrolysis in children","volume":"21","author":"Koh","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.aller.2015.02.004_bib0675","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens\u2013Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0680","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.aller.2015.02.004_bib0685","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaci.2009.10.030","article-title":"CD94\/NKG2C is a killer effector molecule in patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"125","author":"Morel","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0690","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2332\/allergolint.10-RAI-0261","article-title":"Genetic markers and danger signals in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"59","author":"Chung","year":"2010","journal-title":"Allergoll Int"},{"key":"10.1016\/j.aller.2015.02.004_bib0695","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with antiepileptics and allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.aller.2015.02.004_bib0700","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2015.02.004_bib0705","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A 3101 and HLA-B 1502 as genetic markers for carbamazepine hypersensitivity in children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.aller.2015.02.004_bib0710","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/epi.12564","article-title":"Recommendations for HLA-B* 15:02 and HLA* 31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions","volume":"55","author":"Amstutz","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.aller.2015.02.004_bib0715","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/pai.12058","article-title":"Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children","volume":"24","author":"Manuyakorn","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0720","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0725","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.aller.2015.02.004_bib0730","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.2008-1923","article-title":"Medications at risk factors of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children; a pooled analysis","volume":"123","author":"Levi","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2015.02.004_bib0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4065\/mcp.2009.0379","article-title":"Clinical, etiologic, and histopathologic features of Stevens\u2013Johnson syndrome during an 8-year period at Mayo Clinic","volume":"85","author":"Wetter","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.aller.2015.02.004_bib0740","doi-asserted-by":"crossref","first-page":"e2011004","DOI":"10.4084\/mjhid.2011.004","article-title":"Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis","volume":"3","author":"Khalaf","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.aller.2015.02.004_bib0745","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3315\/jdcr.2010.1043","article-title":"Stevens\u2013Johnson syndrome associated with cytomegalovirus infection in a child with ependymoma","volume":"4","author":"Cruz","year":"2010","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.aller.2015.02.004_bib0750","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens\u2013Johnson syndrome caused by Mycoplasma pneumonia infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.aller.2015.02.004_bib0755","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","article-title":"Erithema multiforme Stevens Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years experience","volume":"25","author":"Forman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.aller.2015.02.004_bib0760","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-3083.2010.03935.x","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital","volume":"25","author":"Ferrandiz-Pulido","year":"2011","journal-title":"J Eur Acad Dermatol Veneorol"},{"key":"10.1016\/j.aller.2015.02.004_bib0765","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.109.1.74","article-title":"Long-term consequences of toxic epidermal necrolysis in children","volume":"109","author":"Sheridan","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2015.02.004_bib0770","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2009.06.085","article-title":"Stevens\u2013Johnson s\u00edndrome and toxic epidermal necrolysis in Asian children","volume":"62","author":"Koh","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0775","first-page":"366","article-title":"Clinical characteristics of childhood erythema multiforme Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Taiwanese children","volume":"37","author":"Lam","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.aller.2015.02.004_bib0780","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0213-9251(01)72498-7","article-title":"S\u00edndrome de Stevens\/Johnson\/necr\u00f3lisis epid\u00e9rmica t\u00f3xica","volume":"16","author":"Garc\u00eda-Fernandez","year":"2001","journal-title":"Piel"},{"key":"10.1016\/j.aller.2015.02.004_bib0785","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0790","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation","volume":"42","author":"De Prost","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aller.2015.02.004_bib0795","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s001340050492","article-title":"Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study","volume":"23","author":"Lebargy","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aller.2015.02.004_bib0800","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0805","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORT a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0810","first-page":"16","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: pathogenesis, clinical manifestations, and diagnosis","author":"Nirkom","year":"2014","journal-title":"Up ToDate"},{"key":"10.1016\/j.aller.2015.02.004_bib0815","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2222.2007.02742.x","article-title":"Delayed drug hypersensitivity reactions-new concepts","volume":"37","author":"Posadas","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.aller.2015.02.004_bib0820","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40272-013-0039-z","article-title":"Cutaneous drug reactions in children: an update","volume":"15","author":"Heelan","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.aller.2015.02.004_bib0825","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.140.9.1172","article-title":"Acute generalized exanthematous pustulosis in children","volume":"140","author":"Ersoy","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0830","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1525-1470.2000.017005399.x","article-title":"Acute generalized exanthematous pustulosis (AGEP), an uncommon condition in children: case report and review of the literatura","volume":"17","author":"Meadows","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0835","series-title":"Pediatric dermatology","first-page":"1698","article-title":"Drug reactions","author":"Lansang","year":"2011"},{"key":"10.1016\/j.aller.2015.02.004_bib0840","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I.I. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0845","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2332\/allergolint.55.27","article-title":"Immune mechanisms in drug allergy","volume":"55","author":"Roujeau","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.aller.2015.02.004_bib0850","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/pai.12121","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children","volume":"24","author":"Atanaskovi\u0107-Markovi\u0107","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0855","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0860","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drugs reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.aller.2015.02.004_bib0865","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1398-9995.2004.00678.x","article-title":"Diagnosis of noninmediate reactions to beta-lactam antibiotics","volume":"59","author":"Romano","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2015.02.004_bib0870","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2015.02.004_bib0875","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1710-1492-4-2-66","article-title":"Patch testing in non-immediate drug eruptions","volume":"4","author":"Romano","year":"2008","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib0880","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.iac.2009.04.010","article-title":"Skin testing in delayed reactions to drugs","volume":"29","author":"Barnaud","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.aller.2015.02.004_bib0885","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2015.02.004_bib0890","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.aller.2015.02.004_bib0895","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0900","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archderm.140.7.890","article-title":"Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States","volume":"140","author":"Trent","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0905","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","volume":"126","author":"Gu\u00e9gan","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0910","first-page":"439","article-title":"Epidermal necrolysis (Stevens\u2013Johnson syndrome and toxic epidermal necrolysis)","volume":"vol. 1","author":"Valeyrie-Allanore","year":"2012"},{"key":"10.1016\/j.aller.2015.02.004_bib0915","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/BCR.0b013e3181eed441","article-title":"Toxic epidermal necrolysis in pregnancy: case report and review of the literature","volume":"31","author":"Struck","year":"2010","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.aller.2015.02.004_bib0920","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0305-4179(00)00136-4","article-title":"Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong","volume":"27","author":"Ying","year":"2001","journal-title":"Burns"},{"key":"10.1016\/j.aller.2015.02.004_bib0925","first-page":"185","article-title":"Treatment of toxic epidermal necrolysis with moisture-retentive ointment: a case report and review of the literature","volume":"29","author":"Atiyeh","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.aller.2015.02.004_bib0930","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilization and decreases infection in elderly patients","volume":"34","author":"Boorboor","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.aller.2015.02.004_bib0935","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.109.1.74","article-title":"Treatment of extensive toxic epidermal necrolysis in children","volume":"109","author":"Spies","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2015.02.004_bib0940","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(89)80736-X","article-title":"Management of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children","volume":"115","author":"Prendiville","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2015.02.004_bib0945","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004630-199920060-00012","article-title":"Management of severe toxic epidermal necrolysis in children","volume":"20","author":"Sheridan","year":"1999","journal-title":"J Burn Rehabil"},{"key":"10.1016\/j.aller.2015.02.004_bib0950","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1503\/cmaj.050783","article-title":"Dermatologic emergencies","volume":"173","author":"Freiman","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.aller.2015.02.004_bib0955","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0960","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0884533608323434","article-title":"Energy requirements off pediatric patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"23","author":"Mayes","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.aller.2015.02.004_bib0965","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.aller.2015.02.004_bib0970","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis","volume":"33","author":"Stella","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.aller.2015.02.004_bib0975","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0378-6323.18943","article-title":"Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study","volume":"71","author":"Mangla","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.aller.2015.02.004_bib0980","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib0985","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.iio.0000177430.89645.6d","article-title":"Controversy in the use of high-dose systemic steroids in the acute care of patients with Stevens\u2013Johnson syndrome","volume":"45","author":"Hynes","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.aller.2015.02.004_bib0990","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/archdischild-2013-304909","article-title":"Question 2: would systemic steroids be useful in the management of Stevens\u2013Johnson syndrome?","volume":"98","author":"Corrick","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.aller.2015.02.004_bib0995","first-page":"16","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: management, prognosis, and long-term sequelae","author":"High","year":"2014","journal-title":"Up ToDate"},{"key":"10.1016\/j.aller.2015.02.004_bib1000","first-page":"e21","article-title":"A systematic review of treatment of drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children","volume":"18","author":"Del Pozzo-Magana","year":"2011","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.aller.2015.02.004_bib1005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.2010-3322","article-title":"Recurrence and outcomes of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children","volume":"128","author":"Finkelstein","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2015.02.004_bib1010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib1015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1440-0960.2012.00887.x","article-title":"Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl","volume":"53","author":"Buyurtiryak","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib1020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.aller.2015.02.004_bib1025","first-page":"299","article-title":"Anticonvulsivant drug hypersensitivity","volume":"12","author":"Galindo","year":"2002","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib1030","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMcp1104080","article-title":"Clinical practice exanthematous drug eruptions","volume":"366","author":"Stern","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2015.02.004_bib1035","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic. symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib1040","first-page":"556","article-title":"Clinical features of drug- induced hypersensitivity syndrome in 38 patients","volume":"20","author":"Um","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2015.02.004_bib1045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aller.2015.02.004_bib1050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054615000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054615000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T14:34:17Z","timestamp":1717943657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054615000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0301054615000749"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2015.02.004","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens\u2013Johnson syndrome, toxic epidermal necrolysis and DRESS)","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 SEICAP. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}